News from afraxis, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.


Apr 30, 2013, 08:00 ET

Afraxis, Inc. and Servier Announce a Collaboration on ESP Platform for Drug Discovery in Central Nervous System Disorders

 Afraxis, Inc. ("Afraxis") and Institut de Recherches Servier ("Servier") announced a non-exclusive platform collaboration using Afraxis'...

Apr 29, 2013, 08:00 ET

Afraxis Appoints Carmine Stengone President and Chief Executive Officer, and Christopher Rex, Ph.D., Chief Scientific Officer

 Afraxis, Inc. today announced that it has appointed Carmine Stengone as the company's president and chief executive officer. The company...

Jan 29, 2013, 08:00 ET

Afraxis Grants Exclusive Global License to Genentech

Afraxis, Inc. today announced that it has entered into a global licensing agreement with Genentech, a member of the Roche Group (SIX: RO, ROG;...

Jul 16, 2012, 09:08 ET

Afraxis and PsychoGenics Form Alliance to Offer Afraxis' ESP Technology for Drug Discovery

Afraxis and PsychoGenics today announced an alliance to offer Afraxis' Enhanced Spine Platform (ESP) technology as part of PsychoGenics'...

Sep 26, 2011, 08:00 ET

Afraxis Enters Collaboration with NIH as Part of Therapeutics for Rare and Neglected Disease Program

Afraxis, a San Diego-based biotechnology company developing drugs to treat rare genetic diseases through the modulation of p21-activated kinase...

Mar 08, 2010, 08:00 ET

Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development

Afraxis, a San Diego-based biotechnology company developing drugs to treat central nervous system (CNS) disorders, today announced the appointment...